logo

Search

Login | Create Account

rheumatology


Categories

Bone health Gout JIA Lupus Medicines Medicopolitical Musculoskeletal Osteoarthritis Pain Psoriatic arthritis Public health Rare diseases Research Rheumatoid arthritis Risk factors Scleroderma Spondyloarthritis

Other

Conferences

Specialties


Cardiology Dermatology Endocrinology Gastroenterology Haematology Neurology Oncology Respiratory Rheumatology

General


Contact Us About Us Website Disclaimer Privacy Policy Terms & Conditions

©2022 the limbic

logo

#ARANZ17

Saturday 20th - Wednesday 24th May 2017

Rheumatoid arthritis

Latest registry data confirms no elevated cancer risk with anti-TNFs

The latest analysis of data from the Australian Rheumatology Association Database (ARAD) and national cancer records confirms that any increased risk of cancer in rheumatoid arthritis patients is independent of their exposure to biologics. The findings, presented at the joint meeting...

The latest analysis of data from the Australian Rheumatology Association Database (ARAD) and national cancer records confirms that any increased...


Bone health

Repeat bone density scans often not needed: expert

Repeat bone scans are often not necessary for people with osteoporosis who are taking medications to increase their bone density, an expert says. Updating the conference during a session on controversies in bone disease, endocrinologist and bone specialist Professor Mark Bolland...

Repeat bone scans are often not necessary for people with osteoporosis who are taking medications to increase their bone density,...


Rheumatoid arthritis

Treat-to-target uptake low in rheumatology clinics

Half of all rheumatologists in public and private practice in Australia do not apply the evidence based treat-to-target strategy when treating RA patients, a nationwide survey reveals. Presenting the results of the survey to delegates at the joint Australian Rheumatology Australia...

Half of all rheumatologists in public and private practice in Australia do not apply the evidence based treat-to-target strategy when...


Cancel
Cancel